PubMed Health⌕ Search

Biomedical subjects

N Moulton

Publications and source records attributed to N Moulton.

7 recordsLinked to original sources

Cognitive function among the elderly. Comparison of home care clients and independent seniors.

A cross-sectional survey from the Centre for Rural Health Studies of 210 elderly clients in a rural home care program found that 18.1% had severe or moderate cognitive impairment, yet only 6.6% of 167 elderly community residents living independently in a rural community had similar impairment. While the difference was significant, our methodology could not determine whether a causal association existed.

Activities of Daily Living↗

Cognitive function. Survey of elderly persons living at home in rural Newfoundland.

We tested the cognitive function of elderly, community-dwelling residents in rural Newfoundland using the Canadian Mental Status Questionnaire. The prevalence of moderate and severe cognitive impairment was 9.3%. Physicians in the community had recognized those with severe impairment, but had not recognized any of those with moderate impairment. Cognitive function testing should be part of the periodic health examination of older patients.

Aged↗

Effect of type II diabetes mellitus on cognitive function.

BACKGROUND: As people with diabetes mellitus suffer from peripheral and autonomic neuropathy, we thought it possible that deficits in cognitive function might also be found. Our objective was to compare the cognitive function of elderly persons with non-insulin-dependent diabetes mellitus (NIDDM) with a matched sample of persons without NIDDM: METHODS: Ninety outpatients over 50 years of age with NIDDM and 90 matched nondiabetic patients were recruited for the study. The Modified Mini-Mental State (3MS) and the Delayed Word Recall (DWR) test were used to assess cognitive function. RESULTS: On the 3MS test, the mean score of persons with NIDDM was 75.6, and that of nondiabetic persons was 79.5 (two-tailed t = 3.04, P = .013). On the DWR, the mean score of persons with NIDDM was 3.9, and that of persons without NIDDM was 4.7 (two-tailed t = 3.52, P = .012). CONCLUSIONS: Persons with NIDDM had significantly poorer scores on two tests of cognitive function. Physicians should be aware of this association between type II diabetes and a small but definite impairment of cognitive function.

Aged↗

Cognitive function and glycosylated hemoglobin in older patients with type II diabetes.

The purpose of this study was to assess whether there is a relationship between diabetes control and cognitive function in older persons with type II diabetes. Seventy-seven patients with type II diabetes mellitus-none of whom were taking insulin-were given two cognitive function tests (the Modified Mini-Mental State and the Delayed Word Recall Test) and a HbA1C assay. All patients were living independently at home in rural communities, and under the care of their family doctor. The mean age of the subjects was 67.6 years; the sample consisted of 23 males and 54 females. The mean glycosylated hemoglobin (HbA1C) level was 8.4 (range from 3.1 to 20.0). There was a nonsignificant trend for persons with extreme lower or higher HbA1C levels to have poorer cognitive function as assessed by the Modified Mini-Mental State but not the Delayed Word Recall Test. The effect of glycemic control on cognitive function may not be as clinically relevant as other factors in elderly persons with type II diabetes.

Aged↗

The ratio of diagnosed to undiagnosed diabetes in patients 40 years and older.

A cross-sectional survey of a one in five random sample of apparently healthy adults aged 40 years and older was done in 17 family practice clinics in Newfoundland, in order to pick up previously undiagnosed diabetics, by fasting blood sugar (FBS) measurements. From a sample of 2,087 people, 1,767 were tested. Forty-eight persons had an elevated FBS on the first test, but only 19 had a sustained high FBS when a second test was done. There were 16 previously-known diabetics for each new diabetic found; in this population it was not worth screening healthy persons for diabetes. Testing should be restricted to high-risk people only. As a result of this study, the diabetes prevalence in the 40+ population rose from 12.4% to 13.1%.

Adult↗